Financial Statements 2023

4. Notes to the IFRS Company Financial Statements 4.5 Capital Structure and Financial Instruments

Authorisations Granted by the Annual’ General Meeting of Airbus SE Held on 19 April 2023

On 19 April 2023, the AGM of the Company authorised the Board of Directors, for a period expiring at the AGM to be held in 2024, to issue shares and to grant rights to subscribe for shares in the Company’s share capital for the purpose of: ESOPs and share ‑ related LTIPs, provided that such powers shall be limited to an aggregate of 0.18% of the Company’s authorised share capital (see “– Note 32: Share ‑ Based Payment” of the Consolidated Financial Statements); – funding the Company and its subsidiaries, provided that such powers shall be limited to an aggregate of 0.3% of the Company’s authorised share capital (see “– Note 36.3: Financing Liabilities” of the Consolidated Financial Statements). –

For each operation, such powers shall not extend to issuing shares or granting rights to subscribe for shares if there is no preferential subscription right and for an aggregate issue price in excess of €500 million per share issuance. Also on 19 April 2023, the AGM authorised the Board of Directors for an 18 months period to repurchase up to 10% of the Company’s issued share capital at a price per share not less than the nominal value and not more than the higher of the price of the last independent trade and the highest current independent bid on the trading venues of the regulated market of the country in which the purchase is carried out. Furthermore, the AGM authorised the Board of Directors to determine on a case ‑ by ‑ case basis the share repurchase programmes to be implemented by the Company, if any.

Reconciliation Consolidated to Company Equity and Net Income

The difference between the total shareholders’ equity according to the Consolidated Financial Statements and Company’s Financial Statements as at 31 December 2023 and 2022 is as follows:

2023

(In € million)

2022

Consolidated equity

17,695

12,950

OCI – Restatement of investments from Consolidated to Company Financial Statements Retained Earnings – Restatement of investments from Consolidated to Company Financial Statements

1,951

4,382

(6,398)

(9,819)

Retained Earnings – Valuation investments at historical cost

1,487

1,487

Retained Earnings – Impairment of financial assets

(1,023)

(1,025)

Company’s equity

13,712

7,975

The difference between the net income according to the Consolidated Financial Statements and Company’s Financial Statements for the year ‑ ended 31 December 2023 and 2022 is as follows:

2023

(In € million)

2022

Consolidated net income

3,789

4,247

Income from investments according to Consolidated Financial Statements

(4,357)

(4,012)

Income from investments according to Company Financial Statements

7,452

200

Loss on / Impairment of financial assets

0

0

Other valuation differences

0

0

Company’s net income (Profit or loss for the period)

6,884

435

130

Airbus

Financial Statements 2023